DOAC in severe renal impairment — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Do not supply until the anticoagulant choice is urgently clarified
Dabigatran is substantially renally cleared and is contraindicated or unsuitable in severe renal impairment depending on indication and threshold. A creatinine clearance of 12 mL/min requires urgent clarification before supply. The pharmacist should not substitute antithrombotic therapy independently. Dabigatran capsules should not be opened because bioavailability may increase.
Reference: BNF